The Fondation ARC is pleased to share the call from the Rising Tide Foundation for Clinical Cancer Research, which is seeking innovative research proposals focused on optimizing therapies for pediatric blood cancers. If you are conducting clinical trials aimed at reducing treatment-related toxicities while maintaining efficacy, this is an excellent opportunity to secure funding.
Selected projects may receive up to 30 % of the total trial costs, with funding typically available for up to five years.
The Letter of Intent deadline is November 22, 2024, and the full proposal phase will run from December 6, 2024, to January 24, 2025.
